Sage Therapeutics plans to price its postpartum depression drug Zulresso between $20,000 and $35,000 per course of treatment, if the Food and Drug Administration approves the therapy as expected in December.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,